𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The expression and clinical significance of BRAF in prostate cancer

✍ Scribed by Zhihong Wen; Xiaoli Zou; Guang Yang; Hui Wang

Publisher
Springer
Year
2011
Tongue
English
Weight
295 KB
Volume
10
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

LRIG1 and the liar paradox in prostate c
LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer
✍ Marcus Thomasson; Baofeng Wang; Peter Hammarsten; Anna Dahlman; Jenny Liao Perss πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 487 KB πŸ‘ 1 views

## Abstract The course of prostate cancer varies greatly, and additional prognostic markers are needed. Leucine‐rich repeats and immunoglobulin‐like domains protein 1 (LRIG1) is an endogenous inhibitor of growth factor signaling and a proposed tumor suppressor. Publicly available gene expression da

Frequency and clinical significance of t
Frequency and clinical significance of transition zone cancer in prostate cancer screening
✍ Reissigl, Andreas; Pointner, Josef; Strasser, Hannes; Ennemoser, Othmar; Klocker πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 626 KB

Approximately 20% of prostate cancers originate in the transition zone (TZ). Although transrectal ultrasound (TRUS) and systematic biopsies have improved peripheral zone (PZ) cancer diagnosis, additional biopsies directed into the TZ may further improve cancer detection. To evaluate the frequency a

The clinical significance of MAGEA3 expr
The clinical significance of MAGEA3 expression in pancreatic cancer
✍ Joseph Kim; Howard A. Reber; Oscar J. Hines; Kevork K. Kazanjian; Andy Tran; Xin πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 186 KB πŸ‘ 1 views

## Abstract The MAGEA gene family that encodes cancer testis antigens is differentially expressed in many cancers. Though MAGEA3 expression has been detected in gastrointestinal malignancies, its role in pancreatic ductal adenocarcinoma (PDAC) has not been well established. We assessed 57 patients

The novel tumor-suppressor Mel-18 in pro
The novel tumor-suppressor Mel-18 in prostate cancer: Its functional polymorphism, expression and clinical significance
✍ Wei Wang; Takeshi Yuasa; Norihiko Tsuchiya; Zhiyong Ma; Shinya Maita; Shintaro N πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 339 KB πŸ‘ 1 views

## Abstract Mel‐18 is a member of the polycomb group (PcG) proteins, which are chromatin regulatory factors and play important roles in development and oncogenesis. This study was designed to investigate the clinical and prognostic significance of Mel‐18 in patients with prostate cancer. A total of